Offering
SRNAI
Jun 17
— 0.00
SharonAI Holdings Inc. entered into a Securities Purchase Agreement dated June 17, 2026 to issue and sell securities to multiple purchasers under SEC Rule 506 exemption. The transa…
M&A
TWAV
Jun 17
▲ +0.65
TaoWeave shifted from being a Bittensor ecosystem investor to building operating businesses within it, investing $1 million in UK-based AI company Manako Labs and securing a multi-…
M&A
HLIT
Jun 17
▲ +0.75
Harmonic Inc. completed the divestiture of its Video Business to MediaKind for $145 million in cash, transforming itself into a pure-play broadband company. The transaction strengt…
Earnings
PGR
Jun 17
▲ +0.85
Progressive Corporation reported May 2026 results with net income of $1.445 billion, up 36% year-over-year, driven by 10% growth in net premiums earned and an improved combined rat…
Other
AMAZE
Jun 17
▲ +0.50
Amaze Holdings adopted a new equity incentive plan effective April 28, 2026, subject to shareholder approval, offering various award types including stock options and restricted aw…
Regulatory
VSTM
Jun 17
▲ +0.75
Verastem Oncology announced positive updated results from RAMP 205 evaluating avutometinib plus defactinib combined with standard chemotherapy in first-line metastatic pancreatic c…
M&A
ANIP
Jun 17
▲ +0.50
AstroNova Inc. has entered into a merger agreement with Orion Merger Parent, Inc. and Orion MergerCo X, Inc., dated June 16, 2026. The transaction represents a significant corporat…
Other
OBND
Jun 17
— 0.00
Our Bond, Inc. submitted an 8-K filing with Exhibit 99.1 but provided minimal substantive information. Without specific financial or operational details, market impact cannot be de…
Regulatory
PLBY
Jun 17
— +0.10
Playboy amended its 2021 Equity and Incentive Compensation Plan, raising the overall share limit to 14,262,364 shares with automatic annual increases of up to 4% through 2031. The …
Leadership
ELWT
Jun 17
▲ +0.70
Elauwit Connection announced the appointment of Nick Jones as Chief Information Officer and Chief Operating Officer, replacing Rick Alder who led the company through its IPO phase.…
Leadership
CME
Jun 17
▲ +0.50
CME Group entered into a transition agreement with Chairman and CEO Terrence Duffy, extending his tenure through December 31, 2027. Duffy will serve as CEO through February 28, 202…
Regulatory
SHF4
Jun 17
— 0.00
Shift4 Payments adopted an updated certificate of incorporation authorized to issue 320 million shares including 300 million Class A common shares and 20 million preferred shares. …
Restructuring
ALLO
Jun 17
— 0.00
Allbirds, Inc. amended its certificate of incorporation to change its corporate name to Smartbird, Inc., effective June 15, 2026. The filing also revised the company's business pur…
Offering
VZ
Jun 17
— 0.00
Verizon announced final results of exchange offers to refinance outstanding notes and received requisite consents for proposed indenture amendments eliminating restrictive covenant…
Other
KLNG
Jun 17
▲ +0.75
KOIL Energy Solutions won a major subsea umbilical handling contract requiring deployment of a newly acquired 3,500-metric-ton carousel and an existing fleet asset, with work sched…
M&A
BBBY · FTHM
Jun 17
▲ +0.50
Fathom Holdings Inc. has entered into a merger agreement to acquire Bed Bath & Beyond Inc., with Bed Bath & Beyond shareholders to receive Fathom stock. The transaction combines a …
Other
RSVR
Jun 17
— 0.00
Reservoir Media filed an investor presentation as an exhibit to an 8-K filing. The document contains forward-looking statements about future business opportunities, financial perfo…
Restructuring
AZTR
Jun 17
▲ +0.65
CEO Francisco Salva outlined strategic reorientation initiatives following a $10.5M financing in March, expanding beyond precision dermatology into cosmetic ingredients and biotech…
Regulatory
AVLN
Jun 17
▲ +0.75
Avalyn Pharma announced completion of target enrollment in its Phase 2b MIST clinical trial evaluating AP01 (inhaled pirfenidone) for progressive pulmonary fibrosis, with topline r…
Regulatory
ELTX
Jun 17
▲ +0.75
Elicio Therapeutics reported that three metastatic pancreatic cancer patients achieved confirmed complete responses after receiving ELI-002 7P followed by nivolumab-based therapy, …